Furthermore, a shotgun proteomic platform has been employed to analyze stimulation and inhibition of EGFR by EGF and gefitinib and cetuximab EGFR inhibitors, respectively, on the A431 human epithelial carcinoma cell line as model system [27]. The gene discussed is EGFR; the disease is carcinoma.